Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote USD

Traws Pharma, Inc. (0T20.F)

Compare
0.0000
-6.6000
(-100.00%)
As of September 23 at 8:16:48 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
226
226
226
226
226
Operating Expense
25,136
25,136
20,524
19,853
16,722
Operating Income
-24,910
-24,910
-20,298
-19,627
-16,496
Other Income Expense
-141,613
-141,613
1,350
663
333
Pretax Income
-166,523
-166,523
-18,948
-18,964
-16,163
Net Income Common Stockholders
-54,674
-54,674
-18,948
-18,964
-16,163
Diluted NI Available to Com Stockholders
-54,674
-54,674
-18,948
-18,964
-16,163
Basic EPS
-35.21
-35.21
-22.57
-22.75
-24.00
Diluted EPS
-35.21
-35.21
-22.57
-22.75
-24.00
Basic Average Shares
1,552.6850
1,552.6850
839.5540
836.3290
673.2870
Diluted Average Shares
1,552.6850
1,552.6850
839.5540
836.3290
673.2870
Total Operating Income as Reported
-142,374
-142,374
-20,298
-19,627
-16,496
Total Expenses
25,136
25,136
20,524
19,853
16,722
Net Income from Continuing & Discontinued Operation
-166,523
-166,523
-18,948
-18,964
-16,163
Normalized Income
-24,621
-24,621
-18,948
-18,964
-16,484
EBIT
-24,910
-24,910
-20,298
-19,627
-16,496
EBITDA
-24,898
-24,898
-20,282
-19,613
-16,482
Reconciled Depreciation
12
12
16
14
14
Net Income from Continuing Operation Net Minority Interest
-166,523
-166,523
-18,948
-18,964
-16,163
Total Unusual Items Excluding Goodwill
-141,902
-141,902
--
--
321
Total Unusual Items
-141,902
-141,902
--
--
321
Normalized EBITDA
117,004
117,004
-20,282
-19,613
-16,803
12/31/2021 - 8/29/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers